Cytosorbents (CTSO) Revenue & Revenue Breakdown
Cytosorbents Revenue Highlights
Latest Revenue (Y)
$36.35M
Latest Revenue (Q)
$9.79M
Main Segment (Y)
Grant income
Main Geography (Y)
All other countries
Cytosorbents Revenue by Period
Cytosorbents Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $36.35M | 23.81% |
| 2022-12-31 | $29.36M | -26.80% |
| 2021-12-31 | $40.11M | 1.66% |
| 2020-12-31 | $39.45M | 73.30% |
| 2019-12-31 | $22.77M | 12.41% |
| 2018-12-31 | $20.25M | 51.34% |
| 2017-12-31 | $13.38M | 63.07% |
| 2016-12-31 | $8.21M | 102.33% |
| 2015-12-31 | $4.06M | 28.96% |
| 2014-12-31 | $3.15M | 282.70% |
| 2013-12-31 | $821.79K | 442.17% |
| 2012-12-31 | $151.57K | 320.13% |
| 2011-12-31 | $36.08K | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | -100.00% |
| 2005-05-31 | $10.00K | - |
Cytosorbents generated $36.35M in revenue during NA 2023, up 23.81% compared to the previous quarter, and up 179.48% compared to the same period a year ago.
Cytosorbents Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $9.79M | 12.90% |
| 2023-12-31 | $8.67M | 11.79% |
| 2023-09-30 | $7.75M | -3.94% |
| 2023-06-30 | $8.07M | 2.05% |
| 2023-03-31 | $7.91M | 3.51% |
| 2022-12-31 | $7.64M | 18.25% |
| 2022-09-30 | $6.46M | -11.84% |
| 2022-06-30 | $7.33M | -7.49% |
| 2022-03-31 | $7.92M | -18.29% |
| 2021-12-31 | $9.70M | 8.94% |
| 2021-09-30 | $8.90M | -21.68% |
| 2021-06-30 | $11.37M | 12.05% |
| 2021-03-31 | $10.14M | -12.03% |
| 2020-12-31 | $11.53M | 12.54% |
| 2020-09-30 | $10.25M | 7.62% |
| 2020-06-30 | $9.52M | 16.73% |
| 2020-03-31 | $8.16M | 23.38% |
| 2019-12-31 | $6.61M | 15.40% |
| 2019-09-30 | $5.73M | -2.09% |
| 2019-06-30 | $5.85M | 27.83% |
| 2019-03-31 | $4.58M | -16.35% |
| 2018-12-31 | $5.47M | 7.21% |
| 2018-09-30 | $5.10M | -2.72% |
| 2018-06-30 | $5.25M | 18.32% |
| 2018-03-31 | $4.43M | 3.19% |
| 2017-12-31 | $4.30M | 24.57% |
| 2017-09-30 | $3.45M | 13.41% |
| 2017-06-30 | $3.04M | 17.14% |
| 2017-03-31 | $2.60M | -0.64% |
| 2016-12-31 | $2.61M | 21.92% |
| 2016-09-30 | $2.14M | 15.68% |
| 2016-06-30 | $1.85M | 15.98% |
| 2016-03-31 | $1.60M | 6.81% |
| 2015-12-31 | $1.50M | 39.58% |
| 2015-09-30 | $1.07M | 36.62% |
| 2015-06-30 | $784.28K | 11.33% |
| 2015-03-31 | $704.49K | -19.36% |
| 2014-12-31 | $873.65K | -15.53% |
| 2014-09-30 | $1.03M | 55.36% |
| 2014-06-30 | $665.73K | 16.61% |
| 2014-03-31 | $570.91K | 81.73% |
| 2013-12-31 | $314.16K | 54.33% |
| 2013-09-30 | $203.56K | 59.07% |
| 2013-06-30 | $127.97K | -27.33% |
| 2013-03-31 | $176.10K | -130.00% |
| 2012-12-31 | $-587.04K | -196.98% |
| 2012-09-30 | $605.35K | 1732.05% |
| 2012-06-30 | $33.04K | 95.60% |
| 2012-03-31 | $16.89K | -53.18% |
| 2011-12-31 | $36.08K | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
Cytosorbents generated $9.79M in revenue during Q1 2024, up 12.90% compared to the previous quarter, and up 128.06% compared to the same period a year ago.
Cytosorbents Revenue Breakdown
Cytosorbents Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Grant income | $5.26M | - | - | - | - |
| Other sales | $69.69K | $787.20K | - | - | - |
| Cyto Sorb Sales | - | - | $40.00M | $39.34M | $22.55M |
| Other Sales | - | - | $111.87K | $110.40K | $220.10K |
Cytosorbents's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant income (98.69%), and Other sales (1.31%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other sales | $11.40K | $24.73K | $59.33K | $6.58K | $3.77K | $245.51K | $191.47K | $292.63K | - | - | - | - | - | - | - | - | - | - | - |
| Grant income | $1.05M | $796.77K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cyto Sorb Sales | - | - | - | - | - | - | - | $7.04M | $7.87M | $9.59M | $8.90M | $11.36M | $10.14M | $11.49M | $10.25M | $9.45M | $8.16M | $6.54M | $5.65M |
| Other product sales | - | - | - | - | - | - | - | - | $57.59K | - | - | - | - | - | - | - | - | - | - |
| Other Sales | - | - | - | - | - | - | - | - | - | $106.29K | $797.00 | $4.78K | $41.40K | - | $69.00K | - | $73.30K | $80.00K | - |
Cytosorbents's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Grant income (98.93%), and Other sales (1.07%).
Cytosorbents Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| United States | $5.26M | $968.95K | $1.69M | - | - |
| All other countries | $18.05M | $15.82M | $17.41M | - | - |
| Germany | $12.96M | - | - | - | - |
| U | - | - | - | $1.34M | $2.18M |
| All Other Countries | - | - | - | $17.85M | $8.15M |
| D | - | - | - | - | - |
Cytosorbents's latest annual revenue breakdown by geography, as of Dec 23: All other countries (49.76%), Germany (35.73%), and United States (14.51%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Germany | $2.78M | $3.54M | $6.46M | $3.17M | $3.34M | $2.49M | $2.98M | $3.78M | $5.33M | $3.66M | - | - | - | - | - | - | - | - | - | - |
| United States | $1.05M | $796.77K | $2.38M | $1.35M | $1.54M | $1.75M | $200.47K | $310.63K | $212.34K | $446.74K | $577.45K | - | - | - | - | - | - | - | - | - |
| All other countries | $6.02M | $5.41M | $8.59M | $4.90M | $4.57M | $3.77M | $4.04M | $3.93M | $3.92M | $4.66M | - | - | - | - | - | - | - | - | - | - |
| D | - | - | - | - | - | - | - | - | - | - | - | $6.12M | $5.90M | $5.99M | - | - | - | $4.15M | - | - |
| All Other Countries | - | - | - | - | - | - | - | - | - | - | - | $4.88M | $3.94M | $5.20M | $5.17M | $4.25M | $3.24M | $2.38M | $2.20M | $2.16M |
| U | - | - | - | - | - | - | - | - | - | - | - | $362.03K | $455.49K | $344.20K | $261.50K | $274.57K | $551.34K | $819.92K | $366.54K | $382.11K |
Cytosorbents's latest quarterly revenue breakdown by geography, as of Jun 24: All other countries (61.13%), Germany (28.19%), and United States (10.68%).
Cytosorbents Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.60M |
| AORT | Artivion | $354.00M | $98.02M |
| INGN | Inogen | $315.66M | $88.77M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| TELA | TELA Bio | $58.45M | $16.09M |
| APYX | Apyx Medical | $52.35M | $12.15M |
| CVRX | CVRx | $39.30M | $11.81M |
| CTSO | Cytosorbents | $36.35M | $9.79M |
| OSA | ProSomnus | $27.65M | $7.46M |
| CLPT | ClearPoint Neuro | $23.95M | $7.86M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
CTSO Revenue FAQ
What is Cytosorbents’s yearly revenue?
Cytosorbents's yearly revenue for 2023 was $36.35M, representing an increase of 23.81% compared to 2022. The company's yearly revenue for 2022 was $29.36M, representing a decrease of -26.80% compared to 2021. CTSO's yearly revenue for 2021 was $40.11M, representing an increase of 1.66% compared to 2020.
What is Cytosorbents’s quarterly revenue?
Cytosorbents's quarterly revenue for Q1 2024 was $9.79M, a 12.90% increase from the previous quarter (Q4 2023), and a 23.72% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $8.67M, a 11.79% increase from the previous quarter (Q3 2023), and a 13.43% increase year-over-year (Q4 2022). CTSO's quarterly revenue for Q3 2023 was $7.75M, a -3.94% decrease from the previous quarter (Q2 2023), and a 19.98% increase year-over-year (Q3 2022).
What is Cytosorbents’s revenue growth rate?
Cytosorbents's revenue growth rate for the last 3 years (2021-2023) was -9.37%, and for the last 5 years (2019-2023) was 59.67%.
What are Cytosorbents’s revenue streams?
Cytosorbents's revenue streams in c 23 are Grant income, and Other sales. Grant income generated $5.26M in revenue, accounting 98.69% of the company's total revenue Other sales generated $69.68K in revenue, accounting 1.31% of the company's total revenue, down -91.15% year-over-year.
What is Cytosorbents’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Cytosorbents was Grant income. This segment made a revenue of $5.26M, representing 98.69% of the company's total revenue.